Strs Ohio lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 3.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 18,317 shares of the medical research company’s stock after selling 741 shares during the period. Strs Ohio’s holdings in Agilent Technologies were worth $1,086,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of A. Cribstone Capital Management LLC increased its stake in Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock valued at $125,000 after buying an additional 54 shares in the last quarter. Trust Co. of Vermont increased its stake in Agilent Technologies by 8.1% in the first quarter. Trust Co. of Vermont now owns 2,743 shares of the medical research company’s stock valued at $145,000 after buying an additional 205 shares in the last quarter. CENTRAL TRUST Co increased its stake in Agilent Technologies by 15.3% in the first quarter. CENTRAL TRUST Co now owns 2,994 shares of the medical research company’s stock valued at $158,000 after buying an additional 398 shares in the last quarter. ELM Advisors LLC acquired a new stake in Agilent Technologies during the second quarter valued at about $202,000. Finally, Penserra Capital Management LLC increased its stake in Agilent Technologies by 9.5% in the first quarter. Penserra Capital Management LLC now owns 3,496 shares of the medical research company’s stock valued at $184,000 after buying an additional 304 shares in the last quarter.

Agilent Technologies, Inc. (A) opened at 59.62 on Tuesday. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $61.84. The company’s 50-day moving average price is $60.10 and its 200-day moving average price is $55.88. The firm has a market cap of $19.16 billion, a price-to-earnings ratio of 33.51 and a beta of 1.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, May 22nd. The medical research company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.48 by $0.10. The firm had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Agilent Technologies had a return on equity of 16.49% and a net margin of 13.41%. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.44 EPS. Analysts predict that Agilent Technologies, Inc. will post $2.23 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 26th. Shareholders of record on Monday, July 3rd were issued a $0.132 dividend. The ex-dividend date was Thursday, June 29th. This represents a $0.53 annualized dividend and a yield of 0.89%. Agilent Technologies’s dividend payout ratio (DPR) is 29.78%.

COPYRIGHT VIOLATION NOTICE: “Strs Ohio Has $1.09 Million Stake in Agilent Technologies, Inc. (NYSE:A)” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.watchlistnews.com/strs-ohio-has-1-09-million-stake-in-agilent-technologies-inc-nysea/1488569.html.

Several equities research analysts have issued reports on the company. BidaskClub downgraded Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Saturday. Jefferies Group LLC restated a “buy” rating and set a $66.00 price objective on shares of Agilent Technologies in a report on Wednesday, August 9th. Barclays PLC restated a “buy” rating and set a $67.00 price objective on shares of Agilent Technologies in a report on Wednesday, July 19th. Wells Fargo & Company upgraded Agilent Technologies from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $42.92 to $60.73 in a report on Wednesday, July 12th. Finally, Robert W. Baird lifted their price objective on Agilent Technologies from $57.00 to $62.00 and gave the stock an “outperform” rating in a report on Wednesday, May 24th. Two analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $60.12.

In other news, Director James Cullen sold 15,482 shares of the stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $59.04, for a total value of $914,057.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Patrick Kaltenbach sold 5,000 shares of the stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $61.26, for a total value of $306,300.00. Following the completion of the transaction, the insider now directly owns 45,138 shares of the company’s stock, valued at $2,765,153.88. The disclosure for this sale can be found here. In the last ninety days, insiders sold 112,608 shares of company stock valued at $6,737,509.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.